◼ Archived
Business
🔮 fades ✓
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
Gilead's Trodelvy has received broad FDA approval for first-line treatment of triple-negative breast cancer, shifting the landscape away from traditional chemo.